Early intervention of intravenous KB220IV--neuroadaptagen amino-acid therapy (NAAT) improves behavioral outcomes in a residential addiction treatment program: a pilot study.
Miller M, Chen AL, Stokes SD, Silverman S, Bowirrat A, Manka M, Manka D, Miller DK, Perrine K, Chen TJ, Bailey JA, Downs W, Waite RL, Madigan MA, Braverman ER, Damle U, Kerner M, Giordano J, Morse S, Oscar-Berman M, Barh D, Blum K.
Miller M, et al.
J Psychoactive Drugs. 2012 Nov-Dec;44(5):398-409. doi: 10.1080/02791072.2012.737727.
J Psychoactive Drugs. 2012.
PMID: 23457891
Free PMC article.